Prospective randomized two-arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapy

Journal of Acquired Immune Deficiency Syndromes

Volumn 25, Issue 3, 2000, Pages 221-228

  Tuldrà, Albert ^a   Fumaz, Carmina R ^a   Ferrer, Ma José ^a   Bayés, Ramon ^b   Arnó, Albert ^a   Balagué, Montserrat ^a   Bonjoch, Anna ^a   Jou, Antoni ^a   Negredo, Eugènia ^a   Paredes, Roger ^a   Ruiz, Lidia ^a   Romeu, Joan ^a   Sirera, Guillem ^a   Tural, Cristina ^a   Burger, David ^c   Clotet, Bonaventura ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Adherence; Antiretroviral therapy; Compliance; Intervention

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BLOOD ANALYSIS; CLINICAL PRACTICE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; EDUCATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATIENT COMPLIANCE; PRIORITY JOURNAL; RATING SCALE; VIRUS LOAD;

EID: 0034319263     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200011010-00003     Document Type: Article

References (57)

1. + lymphocyte counts and the risk of progression to AIDS
2. + lymphocytes as prognostic markers of HIV-1 infection
3. Declining morbidity and mortality among patients with advanced human immunodeficiency vires infection
4. Antiretroviral drug resistance: Mechanisms, pathogenesis, clinical significance
5. Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors
6. Antiretroviral drug resistance testing in adults with HIV infection
7. Patient compliance drug failure in protease inhibitor monotherapy
8. How much adherence is enough? A prospective study of adherence to protease inhibitor therapy using MEMSCaps
9. Adherence effectiveness of highly active antiretroviral therapy
10. Adherence to HAART in HIV
11. Adherence to antiretroviral pneumocystis prophylaxis in HIV disease
12. Zidovudine adherence among individuals with HIV infection
13. The extent of non-adherence in a large AIDS clinical trial using plasma dideoxynucleoside concentrations as a marker
14. A cohort study of drug users' compliance with zidovudine treatment
15. Adherence to the antiretroviral treatment in asymptomatic HIV-infected patients
16. Compliance with zidovudine therapy in patients infected with human immunodeficiency virus, type 1: A cross-sectional study in a municipal hospital clinic
17. Sociodemographic and psychological variables influencing adherence to antiretroviral therapy
18. Adherence to highly active antiretroviral therapy (HAART): Elements for intervention and research
19. Non compliance - Or how many aunts has Matilda?
20. The era of adherence to HIV therapy
21. Potential factors affecting adherence with HIV therapy
22. Progress and problems in the fight against AIDS
23. Problemas de adhesión al tratamiento antirretroviral a largo plazo
24. A behavioral medicine perspective on adherence to long-term medical regimens
25. Facilitating adherence to preventive and treatment regimens
26. Self-efficacy mechanisms in human agency
27. Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: Prospective assessment with implications for enhancing compliance
28. Monitoring adherence to HIV-therapy
29. Simultaneous determination of the HIV-protease inhibitors indinavir, nelfinavir, saquinavir and ritonavir in human plasma by reversed-phase high-performance liquid chromatography
30. Efficacy of adding indinavir to previous reverse transcriptase nucleoside analogues in relation to genotypic phenotypic resistance development in advanced HIV- 1-infected patients
31. Better adherence vital in AIDS therapies
32. Rethinking nonadherence: Historical perspectives on triple-drug therapy for HIV disease
33. Implications of HIV treatment advances for behavioral research on AIDS: Protease inhibitors and new challenges in HIV secondary prevention
34. Predicting antiviral compliance: Physicians' responsibilities vs patients' rights
35. Adherence, compliance and HAART
36. Adherence to highly active antiretroviral therapy
37. Adherence and its implications for antiretroviral therapy
38. Protease inhibitors in the homeless
39. Increasing compliance to HIV treatments in the era of protease inhibitors
40. Self-reported adherence to combination antiretroviral medication (ARV) regimens in a community-based sample of HIV-infected adults
41. Virological failure and adherence to antiretroviral therapy in HIV-infected patients
42. Adherence to antiretroviral therapy in HIV disease
43. Virological treatment failure of protease inhibitor therapy in an unselected cohort of HIV-infected patients
44. Adherence and antiretroviral responses to highly active antiretroviral therapy (HAART) in patients infected with human immunodeficiency virus (HIV): Comparison between outpatient clinic and a clinical trials unit
45. Medication adherence strategies for drug abusers with HIV/AIDS
46. Strategies to optimize adherence to highly active antiretroviral treatment
47. Adherence to zidovudine (AZT) among HIV-infected methadone patients: A pilot study of supervised therapy and dispensing compared to usual care
48. Modified directly observed therapy for treatment of human immunodeficiency virus
49. Self-efficacy and relapse in smoking cessation program
50. The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response
51. Indinavir concentrations in hair from patients receiving highly active antiretroviral therapy
52. Simultaneous determination of saquinavir and ritonavir in plasma with a newly developed HPLC method
53. Measuring medication compliance using repeated pill counts and riboflavin tracer assay
54. Compliance in clinical trials